Tag Archives: some

Zantac and some OTC meds found to contain suspected carcinogen first discovered in blood pressure drugs

The saga of potentially dangerous impurities in the U.S. drug supply continues. A suspected cancer-causing impurity that has been found in some blood pressure medicines has now shown up in Sanofi’s Zantac and some over-the-counter heartburn drugs.  At this point, the FDA says that while N-nitrosodimethylamine (NDMA) has been discovered in these ranitidine medicines like… Read More »

Big Health wants you to cure your insomnia with its app, then delete it — some investors hate that

Peter Hames Big Health CEO Peter Hames wants people to use his app to treat their insomnia — and then delete it for good. His app, Sleepio, essentially works by leveraging an approach known as cognitive behavioral therapy, which aims to give users the tools to manage their own thought patterns differently and overcome their anxieties.… Read More »

AMIA suggests some fine-tuning for FDA’s AI and machine learning regs

The American Medical Informatics Association has offered a list of suggestions to the U.S. Food and Drug Administration in hopes of improving its framework of proposed regulations for artificial intelligence, machine learning and software-as-a-medical-device, or SaMD. WHY IT MATTERSWith an eye toward improving the effectiveness, efficiency, safety and security of clinical AI and SaMD, AMIA… Read More »